TQS-168 receives orphan drug status, aiding als treatment development
ALS News Today - 24-Jun-2022Early trials show safety, tolerability, and promising results in preclinical studies
Previously the Live Forever Club — same community, now with a sharper mission for life extension
Science journalist
Lindsey earned her PhD in neuroscience from Emory University in Atlanta, where she studied novel therapeutic strategies for treatment-resistant forms of epilepsy. She was awarded a fellowship from the American Epilepsy Society in 2019 for this research. Lindsey also previously worked as a postdoctoral researcher, studying the role of inflammation in epilepsy and Alzheimer’s disease.
Visit website: https://alsnewstoday.com/author/lindsey-shapiro/
See alsoDetails last updated 11-Dec-2024
Early trials show safety, tolerability, and promising results in preclinical studies